Clovis Oncology: A Winning Or Losing Lottery Ticket?

When it comes to investing in small biotechnology stocks, it’s like buying lottery tickets. There is a tiny chance to win big, and a huge chance to lose part or all of the funds you invested in these companies. There is a good reason for this. Small biotech companies must commit a great deal of funds in developing products that have to pass three tests: The R&D test, the FDA test and the market test. Investing in Clovis Oncology seems to be like buying a losing lottery ticket, for example -- at least based on the action in the company’s stock. Investors who purchased the stock in the last twelve months are big losers. But it is still a winning ticket for investors who purchased the stock five years ago. Clovis’ Stock Performance